An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes

By Awada A.   Biganzoli L.   Cufer T.   Beex L.   Lohrisch C.   Batter V.   Hamilton A.   Nooij M.   Piccart M.  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 773-778

Elsevier

Access to resources Recommend Favorite

The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures

By Du Yueyao  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 839-848

Springer Publishing Company

Access to resources Recommend Favorite

Holding back the sea: the role for maintenance chemotherapy in metastatic breast cancer

By Murphy C.  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 177-179

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer metastatic to abdomen and pelvis: role of surgical resection*

By Eitan R.   Gemignani M.L.   Venkatraman E.S.   Barakat R.R.   Abu-Rustum N.R.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 397-401

Elsevier

Access to resources Recommend Favorite

The role of FOXP3 in the development and metastatic spread of breast cancer

By Douglass Stephen  

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 843-854

Springer Publishing Company

Access to resources Recommend Favorite